Showing results (641-650 of 2,465) with videos related to
Sort By:
Pageof 247
Cancer Treatment Reviews|December 28, 2020
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancerIlenia Migliaccio, Martina Bonechi, Amelia McCartney, et al.Cancer Treatment Reviews|December 11, 2019
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancerFilippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.Cancer Treatment Reviews|April 6, 2020
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic targetV Gambardella, J Castillo, N Tarazona, et al.Cancer Treatment Reviews|October 1, 2020
The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 ×5 Gy) in rectal cancer - are we too eager for surgery?R Glynne-Jones, M Hall, I D NagtegaalCancer Treatment Reviews|March 24, 2020
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptorRafael Morales-Barrera, Cristina Suárez, Macarena González, et al.Cancer Treatment Reviews|March 18, 2020
Targeting complex, adaptive responses in melanoma therapyPhil Cheng, Mitchell Paul Levesque, Reinhard Dummer, et al.Cancer Treatment Reviews|October 17, 2020
Newly diagnosed ovarian cancer: Which first-line treatment?Domenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.Cancer Treatment Reviews|July 14, 2021
Repositioning PARP inhibitors in the treatment of thoracic malignanciesFrancesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, et al.Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.Cancer Treatment Reviews|June 23, 2017
Bruton's tyrosine kinase (BTK) as a promising target in solid tumorsJ Molina-Cerrillo, T Alonso-Gordoa, P Gajate, et al.Pageof 247